Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders
12 août 2024 07h00 HE
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Selects Initial Indications for Lead Clinical Candidate Targeting Autoimmune Disorders
Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments
08 août 2024 06h30 HE
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Enters into Exclusive License Agreement with AstraZeneca for Multiple Assets to Advance Potential First-in-Class Treatments
Conduit Pharmaceuticals Receives Patent Approval For Its Lead Asset Targeting Autoimmune Diseases
16 juil. 2024 07h30 HE
|
Conduit Pharmaceuticals
SAN DIEGO and LONDON, July 16, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals" or "Conduit" or the “Company”) today announced the approval of a...
Conduit Pharmaceuticals to Join Russell 3000® Index
13 juin 2024 08h00 HE
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals to Join Russell 3000® Index
Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
19 mars 2024 07h00 HE
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals Appoints Dr. Joanne Holland as Chief Scientific Officer
Conduit Pharmaceuticals Announces Opening of Prime Laboratory Space in Europe’s Leading Life Sciences Hub
11 mars 2024 07h00 HE
|
Conduit Pharmaceuticals
SAN DIEGO and LONDON, March 11, 2024 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) ("Conduit Pharmaceuticals" or "Conduit") today announced the opening of cutting-edge laboratory...
Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
31 janv. 2024 08h30 HE
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference
02 nov. 2023 08h30 HE
|
Conduit Pharmaceuticals
Conduit Pharmaceuticals to Participate in the 14th Annual Jefferies London Healthcare Conference
Conduit Pharmaceuticals Partners with ClinConnect on Cocrystal Development Program for AZD1656
11 oct. 2023 08h30 HE
|
Conduit Pharmaceuticals
SAN DIEGO and LONDON, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq: CDT) (“Conduit Pharmaceuticals” or “Conduit”), a multi-asset clinical-stage disease-agnostic life...
Conduit Pharmaceuticals and Murphy Canyon Acquisition Corp. Announce Completion of Business Combination
22 sept. 2023 09h01 HE
|
Conduit Pharmaceuticals
SAN DIEGO, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Limited (“Conduit Pharmaceuticals”), a multi-asset clinical-stage disease-agnostic life science company providing an efficient...